Physician profile
Stephan Finical
NPI 1740364819
$196,418.70
in general payments reported to CMS, 2019-2025
10 companies · $2,958 in 2025
The $2,958 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $6,987 · 2021: $33K · 2022: $54K · 2023: $26K · 2024: $31K · 2025: $2,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Consulting Fee: $23K · Food and Beverage: $3,564 · Travel and Lodging: $2,886 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,650.06 |
| Consulting Fee | $22,531.25 |
| Food and Beverage | $3,564.26 |
| Travel and Lodging | $2,886.04 |
| Education | $101.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $136,552.08 | 2019-2022 | |
| Abbvie INC. | $59,359.04 | 2022-2025 | |
| Davol INC. | $178.64 | 2022-2024 | Arista Ah Flexitip |
| Musculoskeletal Transplant Foundation INC. | $117.76 | 2025 | |
| Motiva USA, LLC | $61.51 | 2025 | |
| Mentor Worldwide LLC | $38.22 | 2022 | |
| Tela Bio, INC. | $37.53 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Galderma Laboratories, L.P. | $34.95 | 2019-2024 | |
| Revance Therapeutics, INC. | $25.72 | 2024 | Daxxify |
| Merz North America, INC. | $13.25 | 2023 | Xeomin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephan Finical listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.